new_0222_0342|EWTX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0342|EWTX|1|Edgewise Therapeutics Inc Total Current Assets (Quarterly) (USD)|Edgewise Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Edgewise Therapeutics Inc Inventories (Quarterly) (USD)|Edgewise Therapeutics Inc Net PP&E (Quarterly) (USD)|Edgewise Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Edgewise Therapeutics Inc Total Liabilities (Quarterly) (USD)|Edgewise Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Edgewise Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Edgewise Therapeutics Inc Total Deposits (Quarterly) (USD)|Edgewise Therapeutics Inc Book Value (Quarterly) (USD)|Edgewise Therapeutics Inc Retained Earnings (Quarterly) (USD)|Edgewise Therapeutics Inc Treasury Stock (Quarterly) (USD)|Edgewise Therapeutics Inc EV to Revenues|Edgewise Therapeutics Inc EV to Earnings|Edgewise Therapeutics Inc EV to Free Cash Flow|Edgewise Therapeutics Inc EV to Assets (Quarterly)|Edgewise Therapeutics Inc PS Ratio|Edgewise Therapeutics Inc PE Ratio|Edgewise Therapeutics Inc Price to Book Value|Edgewise Therapeutics Inc PEG Ratio|Edgewise Therapeutics Inc Debt to Equity Ratio|Edgewise Therapeutics Inc Dividend Yield|Edgewise Therapeutics Inc Shareholder Yield (TTM)|Edgewise Therapeutics Inc Percent of Shares Outstanding Short|Edgewise Therapeutics Inc Total Receivables (Quarterly) (USD)|Edgewise Therapeutics Inc Total Payables (Quarterly) (USD)|Edgewise Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Edgewise Therapeutics Inc Return on Invested Capital|Edgewise Therapeutics Inc Quality Ratio Score|Edgewise Therapeutics Inc Momentum Score|Edgewise Therapeutics Inc Beta (1Y)|Edgewise Therapeutics Inc Sustainable Growth Rate (TTM)|Edgewise Therapeutics Inc Institutional Investor Ownership Percentage|Edgewise Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Edgewise Therapeutics Inc Total Employees (Annual)|Edgewise Therapeutics Inc EPS Diluted (Quarterly) (USD)|Edgewise Therapeutics Inc Shares Outstanding|Edgewise Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Edgewise Therapeutics Inc Ordinary Shares Number (Quarterly)|Edgewise Therapeutics Inc Payout Ratio|Edgewise Therapeutics Inc Quick Ratio (Quarterly)|Edgewise Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Edgewise Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Edgewise Therapeutics Inc Effective Tax Rate (TTM)|Edgewise Therapeutics Inc Return on Equity|Edgewise Therapeutics Inc Net Income (TTM) (USD)|Edgewise Therapeutics Inc Revenue (TTM) (USD)|Edgewise Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Edgewise Therapeutics Inc Revenue (Quarterly) (USD)|Edgewise Therapeutics Inc Gross Profit (Quarterly) (USD)|Edgewise Therapeutics Inc SG&A Expense (Quarterly) (USD)|Edgewise Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Edgewise Therapeutics Inc Net Income (Quarterly) (USD)|Edgewise Therapeutics Inc Net Interest Income (Quarterly) (USD)|Edgewise Therapeutics Inc Price (USD)|Edgewise Therapeutics Inc Total Return Price (USD)|Edgewise Therapeutics Inc Enterprise Value (USD)|Edgewise Therapeutics Inc 30-Day Average Daily Volume|Edgewise Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0342|EWTX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0342|EWTX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0342|EWTX|5|91.25|91.25||91.25||91.25|91.25|91.25||91.25|91.25||||1.44534412955||||1.44262295082|||1.44534412955||15.1818181818||91.25|91.25|||||||91.4285714286|91.25|91.4285714286|31.5||91.25|||91.4285714286|91.4285714286|||91.25|||||91.4285714286|91.4285714286|91.4285714286|91.4285714286|1.44534412955|1.44534412955|1.44534412955|1.44495412844|||
new_0222_0342|EWTX|6|4|4||4||4|4|4||4|4||||247||||244|||247||22||4|4|||||||7|4|7|10||4|||7|7|||4|||||7|7|7|7|247|247|247|218|||
new_0222_0342|EWTX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0342|EWTX|202003||||||||||||||||||||||||||||||||||20.3381||-0.1566||||||-0.1566|||||||||0.281|-3.185|-3.185|0.063|||||||
new_0222_0342|EWTX|202006||||||||||||||||||||||||||||||||||20.3381||-0.1944||||||-0.1944|||||||||0.318|-3.954|-3.954|0.003|||||||
new_0222_0342|EWTX|202009||||||||||||||||||||||||||||||||||20.3381||-0.1791||||||-0.1791|||||||||0.405|-3.642|-3.642|0.001|||||||
new_0222_0342|EWTX|202012|129.645|129.094||0.516||164.556|4.342|160.214||-33.42|-34.147|||||||||||||||1.58||||||||46.567|19|-0.1362|||49.262|||-0.1362||||-17.123|||||1.205|-6.342|-6.342|0.002|||||||
new_0222_0342|EWTX|202103|310.545|309.871||0.499||4.851|4.851|||306.394|-40.962||||-70.8971||||5.2245|||||1.0864||1.621|0.005|||||||1.5599|22|-4.37|49.2543||49.2543|||-4.37|-187.051|||-20.753|||||1.497|-6.815|-6.815|0.042|32.5|32.5|1290.8938|134401.0333||28.64|28.87
new_0222_0342|EWTX|202106|302.969|299.151||0.524||6.739|6.739|||296.749|-51.315||||-31.4746||||3.5409|||||3.9577||2.816|0.005|||||||49.2584|26|-0.21|49.262||49.262|||-0.21|0.903|||-27.152|||||2.599|-10.353|-10.353|0.107|21.33|21.33|751.6125|266735.0667||17.51|15.84
new_0222_0342|EWTX|202109|293.242|290.484||0.911||9.049|8.754|0.295||285.399|-64.264||||-18.0053||||2.8673|||||3.2113||2.292|0.005|||||||49.2649|30|-0.26|49.2958||49.2958|||-0.26||||-36.459|||||3.196|-12.949|-12.949|0.127|16.6|16.6|527.8263|64083.2333||16.5|17.42
new_0222_0342|EWTX|202112|283.773|280.789||0.912||10.85|10.521|0.329||274.383|-76.96||||-13.9159||||2.7566|||||7.0824||3.843|0.005|||||||49.4978|31|-0.24|49.5003||49.5003|||-0.24||||-42.813|||||3.734|-12.696|-12.696|0.126|15.28|15.28|475.5756|378933.8333||13.6|11.79
new_0222_0342|EWTX|202203|||||||||||||||-8.2709||||2.0535||||||||||||||||||||||||||||||||||||11.38|11.38|282.6576|238875.0333|||